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Abstract
Background: The purpose of this study was to evaluate the long-term results of partial liver
resection for benign liver lesions.
Methods: All patients operated on for benign liver lesions from 1991 to 2002 were included.
Information was retrieved from medical records, the hospital registration system and by a
telephonic questionnaire.
Results: Twenty-eight patients with a median age of 41 years (17–71) were operated on (M/F ratio
5/23). The diagnosis was haemangioma in 8 patients, FNH in 6, HCA in 13 and angiomyolipoma in
1. Eight patients were known to have relevant co-morbidity. Median operating time was 207
minutes (45–360). The morbidity rate was 25% and no postoperative mortality was observed.
Twenty-two patients (79%) had symptoms (mainly abdominal pain) prior to surgery. Twenty-five
patients were reached for a questionnaire. The median follow up was 55 months (4–150). In 89%
of patients preoperative symptoms had decreased or disappeared after surgery. Four patients
developed late complications.
Conclusion: Long-term follow up after liver surgery for benign liver lesions shows considerable
symptom relief and patient satisfaction. In addition to a correct indication these results justify major
surgery with associated morbidity and mortality.
Background
Partial liver resection is an accepted treatment for primary
and secondary malignancies of the liver. In experienced
hands this operation is associated with mortality rates of
less than 5% and morbidity of approximately 30% [1-4].
Unlike malignant liver tumours, the indication for resec-
tion of benign hepatic lesions, including haemangiomas,
focal nodular hyperplasia (FNH) and hepatocellular ade-
nomas (HCA) remains controversial [5-7]. Indications for
resection of benign liver masses include: 1) severe or pro-
gressive symptoms, 2) uncertain diagnosis with a suspi-
cion for malignancy, and 3) risk of haemorrhage or
rupture. If possible, it is important to discern whether the
presenting symptoms are due to the liver lesion detected,
before proceeding with surgical intervention. Several stud-
ies have reported about the indication for surgery in vari-
ous benign hepatic tumours. However, less is known
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about the long-term results of surgical treatment, particu-
larly regarding symptom relief.
The present study was undertaken to evaluate the long-
term results of partial liver resections for benign liver
lesions, with emphasis on the course of symptomatology,
long-term complication rate, and patient satisfaction.
Methods
All patients treated by partial liver resection for benign
lesions in the University Medical Centre Utrecht between
January 1991 and December 2002 were included. Infor-
mation about these patients was retrieved from medical
records and the hospital registration system.
Preoperative parameters consisted of age, sex, diagnosis,
co-morbidity, presenting symptoms and indication for
resection. In the preoperative work up we have routinely
performed physical diagnostic investigation, ultrasound
and computed tomography (CT) to exclude other pathol-
ogy causing the symptoms. On indication additional gas-
troscopy or endoscopic retrograde
cholangiopancreatography was performed. The indica-
tions for resection of a haemangioma were persisting
symptoms and rapid growth. After exclusion of other pain
aetiology a period of 3 months observation was allowed
to asses the persistence of the symptoms. In case of FNH
the indications for resection were persisting symptoms
and to exclude malignancy. HCA's were resected if symp-
tomatic or larger than 5 cm.
Date of resection, extent of resection, number of perioper-
ative blood transfusions and duration of resection were
considered perioperative parameters. A major resection
was defined as a resection of three segments or more. Peri-
operative blood transfusion was defined as at least one
unit of packed cells infused within 24 hours after surgery.
Documented postoperative parameters consisted of clini-
cally relevant complications, postoperative mortality,
duration of admission and follow up. Postoperative mor-
tality was defined as in-hospital mortality. Long-term fol-
low up was obtained by a telephonic questionnaire.
Information was collected about the presenting symp-
toms, the relief of these symptoms after surgery and the
impact on physical and social activities. The limitations
on physical and social activities as a result of the present-
ing symptoms were divided in severe, moderate and none.
Moderate limitations were defined as limitations for activ-
ities at least once a week, while severely limited patients
experienced daily restrictions. Symptom relief was defined
as a decrease or absence of the presenting symptoms after
surgery.
Results
A total of 28 patients were operated on for benign liver
lesions. The diagnosis was a haemangioma in 8 patients
(29%), FNH in 6 (21%), HCA in 13 (46%) and angiomy-
olipoma in 1 (4%). The group consisted of 23 female and
5 male patients with a median age of 41 years (range 17–
71). Eight patients (29%) were known to have relevant co-
morbidity, including severe cardiac or pulmonary dis-
eases, diabetes mellitus, hepatitis, liver fibrosis, adipositas
and multiple sclerosis.
Twenty-two patients were known to have symptoms prior
to surgery (79%). The most frequent presenting symptom
was upper abdominal pain (64%). Other presenting
symptoms are shown in table 1. The most important indi-
cations for resection were symptoms and excluding malig-
nancy (table 2). The symptoms mentioned in this table
consisted of abdominal pain in all patients. Three patients
with HCA presented with haemorrhage as a result of spon-
taneous rupture. One patient was immediately operated
on. The other 2 patients were stabilized and resection was
performed after the haematoma was resolved.
All operations concerned partial liver resections, of which
11 resections were major (39%) (Table 3). The median
operating time was 207 minutes (range 45–360). Eight-
een procedures necessitated perioperative blood transfu-
sions (median 2, range 0–16).
One patient underwent extended left hemihepatectomy
for an asymptomatic, but rapidly growing giant haeman-
gioma (25 cm). This major resection was accompanied by
massive intraoperative haemorrhage from direct venous
hepatocaval branches (7500 ml). After the resection the
Table 1: Predominant presenting symptoms in 28 patients
Symptom Haemangioma (n = 8) FNH (n = 6) HCA (n = 13) Angiomyolipoma (n = 1) Total (n = 28)
Abdominal pain 7 4 7 0 18
Swelling 1 1 0 1 3
N a u s e a 0 0 101
No symptoms 0 1 5 0 6BMC Surgery 2005, 5:7 http://www.biomedcentral.com/1471-2482/5/7
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transected surface kept oozing. Therefore haemostasis was
obtained by packing with gauzes. About 36 hours later the
gauzes were removed. Further postoperative recovery was
uneventful. A second patient underwent reoperation for
wound dehiscence. The median hospital stay was 9.5 days
(range 5–39). Seven patients developed one or more post-
operative complications resulting in a morbidity rate of
25% (table 4). No postoperative mortality was observed.
During follow up one patient died as a result of a cause
other than liver surgery. Three months after a left
hemihepatectomy for a large tumour which turned out to
be a angiomyolipoma this patient died of cerebral stroke.
Of the remaining 27 patients we were able to contact 25
for a questionnaire (figure 1). The median follow up of
the interviewed patients was 55 months (range 4–150).
Six of the 25 interviewed patients had no symptoms prior
to surgery and underwent resection because of an uncer-
tain diagnosis of an incidentally discovered liver lesion.
Before surgery 7 patients were severely limited in their
physical activities as a result of the liver lesion, 5 were
moderately limited and 13 were not limited. Considering
social activities 4 patients were severely limited prior to
surgery, 4 were moderately limited and 17 were not lim-
ited. After surgery the symptoms had decreased or disap-
peared in 17 of the 19 interviewed patients with
preoperative symptoms (89%). In two patients the symp-
toms were unchanged. One patient underwent partial
liver resection for an adenoma. After the resection the pre-
operative abdominal pain never decreased. In a second
patient preoperative abdominal pain did not decrease
after resection of a large haemangioma. In these two cases
the preoperative symptoms were probably not related to
the liver lesion. Four of the 25 interviewed patients had
developed late complications as a result of the operation.
These complications consisted of a hypertrophic scar (n =
2) and incisional hernia (n = 2). Twenty-three of 25
Table 2: Indication for resection in 28 patients
Indication Haemangioma (n = 8) FNH (n = 6) HCA (n = 13) Angiomyolipoma (n = 1) Total (n = 28)
Symptoms 7 1 3 0 11
Excluding malignancy 0 5 5 1 11
H a e m o r r h a g e 0 0 303
Risk of malignant degeneration 0 0 2 0 2
S i z e 1 0 001
Table 3: 28 Partial liver resections
Extent of resection
Diagnosis Patients L Hemi R Hemi Ext R Segm
H a e m a n g i o m a 81115
F N H 60204
H C A 1 3 040 9 *
A n g i o m y o l i p o m a 11000
A l l 2 8 271 1 8
L Hemi = Left hemihepatectomy
R Hemi = Right hemihepatectomy
R Ext = Extended right hemihepatectomy
Segm = Segmentectomy
* One patient treated with a central resection segment 4, 5 and 8
Table 4: Seven patients with 8 postoperative complications
Complication Patients
Wound infection 2
Urinary tract infection 2
Bile leakage 1
Severe ascites 1
Pneumonia 1
Deep venous thrombosis 1
Total 8BMC Surgery 2005, 5:7 http://www.biomedcentral.com/1471-2482/5/7
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interviewed patients were satisfied with the result of the
resection (92%).
Discussion
Symptom relief was observed in 89% of the patients (17/
19), while in two patients the preoperative symptoms had
not decreased. Only a few studies concerning long-term
follow up of resections for benign liver tumours have been
published. Terkivatan et al. described 80% symptom relief
in surgically treated patients [5]. In this study surgery was
only indicated in case of suspicion of malignancy, severe
or increasing symptoms or a HCA larger than 5 cm. They
compared this group retrospectively with patients treated
conservatively, of whom 34% presented with symptoms,
e.g. non-specific complaints of fatigue and mild abdomi-
nal pain considered unrelated to the tumour. During
long-term follow up 87% symptom relief was observed in
the group who was treated conservatively. Charny et al.
registered 93% symptom regression in patients who
underwent partial liver resection for benign liver tumours
and 86% symptom regression in patients who were
observed for symptoms considered unrelated to the
tumour or treated for unrelated conditions [8]. Therefore
partial liver resection for a symptomatic liver lesion
should only be performed when symptoms are most
likely related to the lesion.
Because of the nature of benign liver tumours, clear indi-
cations are needed for partial liver resection, an operation
associated with substantial postoperative morbidity and
mortality. Indications for resection of a cavernous hae-
mangioma of the liver are the development of complica-
tions, rapid growth, the presence of persisting symptoms
or the need to establish a confident diagnosis. The poten-
tial for complications of a liver haemangioma (mainly
rupture) is not an indication for resection of all liver hae-
mangiomas. Spontaneous rupture of a haemangioma is
infrequent and could be controlled with transcatheter
hepatic artery embolization prior to resection [9]. As for
rapid growth, we have operated on 1 patient with an
asymptomatic, but rapidly growing haemangioma in our
series. Little is known about the natural history of these
large haemangiomas and resection can be very challeng-
ing, since they are at risk for massive intraoperative haem-
orrhage. In case of abdominal pain the main challenge is
to determine whether these symptoms are due to the hae-
mangioma or an associated condition [10-12]. Farges et
al. described other pain aetiology in 54% of patients with
symptomatic haemangiomas [7]. Gandolfi et al. observed
only 7% symptomatic giant haemangiomas in their series
[13]. Haemangiomas are not likely to cause diagnostic
uncertainty. In our series we have not performed diagnos-
tic resections for haemangiomas.
Unlike FNH, HCA is often symptomatic and is noted for
its spontaneous rupture and malignant transformation.
Looking at the potential complications, HCA's with a
diameter of more than 5 cm should be resected, while for
smaller HCA's and FNH observation is justifiable [6,14-
16]. Increasing size on radiographic imaging during
observation is an indication for resection. FNH and HCA
occur predominantly in females and are associated with
long-term contraceptive steroid use [17]. This medication
should be stopped, when FNH or a small HCA is not
treated surgically. In case of FNH and HCA the most fre-
quent indication for resection is the uncertain diagnosis of
a hepatic mass with suspicion for malignancy. In addition
to ultrasound, CT and MRI, positron emission tomogra-
phy has proved to be a helpful modality distinguishing
between benign and malignant liver lesions [18,19]. On
the other hand, the use of needle biopsy should be
reserved for atypical cases, since the limited material is
rarely sufficient to exclude malignancy. In our series diag-
nostic uncertainty accounted for operation in 11 of 20
resected patients and was, together with symptoms, the
main indication for resection. The final diagnosis after
pathological examination of resected specimens was FNH
in 5 patients, HCA in 5 and angiomyolipoma in 1. All
Patients summary Figure 1
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HCA's were larger than 5 cm, but no malignancies were
observed.
Conclusion
We have shown in this consecutive series that partial liver
resection for benign disease is a very effective procedure to
relief invalidating abdominal symptoms. Benign liver
lesions should only be resected when symptoms are most
likely related to the lesion. In experienced centres the
resection can be performed with acceptable morbidity
and low mortality.
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